First-in-human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of CC-90001

NCT02110420 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: CC-90001
DRUG: CC-90001
DRUG: CC-90001
DRUG: CC-90001
DRUG: CC-90001
DRUG: CC-90001
DRUG: CC-90001
DRUG: CC-90001
DRUG: CC-90001
DRUG: CC-90001
DRUG: Placebo
DRUG: CC-90001
DRUG: CC-90001
DRUG: CC-90001

Sponsor

Celgene Corporation